Interspecies transcriptomic comparison identifies a potential porto‐sinusoidal vascular disorder rat model suitable for in vivo drug testing

Abstract

AbstractBackgroundPorto‐sinusoidal vascular disorder (PSVD) involves a group of rare vascular liver diseases of unknown aetiology that may lead to the development of portal hypertension and its life‐threatening complications. Its pathophysiology is not well understood, and animal models described to date do not fully recapitulate human disease.MethodsWe developed three different PSVD rat models by either immunosensitization (repetitive intraportal LPS or intramuscular spleen extract injections) or toxic (Selfox: combination of FOLFOX and a selenium‐enriched diet) treatment and characterized them at haemodynamic, histological, biochemical and transcriptional levels. We compared these results to human data.ResultsAll three models developed significant portal hypertension, while only the LPS and the Selfox models displayed PSVD‐specific and nonspecific histological alterations in the absence of cirrhosis. Transcriptional comparison between rat models and human data showed that both LPS and Selfox models recapitulate the main transcriptional alterations observed in humans, especially regarding haemostasis, oxidative phosphorylation and cell cycle regulation. Reproducibility and feasibility was higher for the Selfox model.ConclusionsThe Selfox rat model faithfully reproduces the main alterations described in PSVD. Its use as a preclinical model for drug testing in progressing PSVD can be a significant step forward towards the development of new therapeutic targets for this rare condition.